Navigation Links
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Date:8/26/2007

Trial to be Stopped Early to Allow All Patients Access to Nexavar

WAYNE, N.J. and EMERYVILLE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a planned review by an independent data monitoring committee (DMC) found that Nexavar(R) (sorafenib) tablets significantly improved overall survival, progression free survival, and time to progression in an Asia-Pacific regional Phase 3 trial of patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer. Based on the DMC's recommendation, the trial will be stopped to allow all patients to receive treatment with Nexavar. Data from this study will be submitted for presentation at an upcoming scientific meeting.

The Asia-Pacific liver cancer study was conducted at the request of Asian health authorities in order to provide supplemental information on Nexavar's efficacy and safety in Asia-Pacific patient populations. Supplemental regulatory filings have been completed in several countries/regions including Europe, China and the United States for Nexavar in the treatment of liver cancer. These filings were based on positive data from the pivotal Phase 3 SHARP study announced earlier this year. Additional regulatory submissions for Nexavar in liver cancer are being finalized.

"Liver cancer incidence continues to rise in the Asia-Pacific region, due to the high prevalence of hepatitis B vi
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.; Onyx
Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
2. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
3. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
7. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
8. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
11. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... SAN DIEGO and CAMBRIDGE, Mass., May 17, 2013 ... announce that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: ... District Court for the District of Massachusetts ... of its officers violated the Securities Exchange Act of ... May 1, 2013 (the "Class Period"). (Logo: ...
(Date:5/17/2013)...  TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8
(Date:5/17/2013)... Lake Arrowhead, CA (PRWEB) May 17, 2013 ... without extra health complications, but for diabetics, treatment is ... diabetics involves additional medical care to monitor blood sugar ... an addicted diabetic properly, a drug rehab for ... the unique dietary and nutritional needs of the diabetic, ...
(Date:5/17/2013)... sleep on mood, memory and learning was given ... Intel International Science and Engineering Fair (ISEF)the world,s ... awards are coordinated by the National Institute on ... of Health, and Friends of NIDA, a coalition ... Science Awards were presented at a ceremony Thursday ...
(Date:5/17/2013)... (HealthDay News) -- Too few obstetrics-gynecology residents in the ... lead to care issues for the rapidly growing number ... Researchers surveyed 510 ob/gyn residents and found that fewer ... menopause medicine, even though seven in 10 would like ... of fourth-year residents -- those soon to complete their ...
(Date:5/17/2013)... Working with lab mice models of multiple sclerosis (MS), ... for the design of drugs that could be safer ... , The findings of the research study, published ... could have therapeutic applications for MS as well ... loss of white matter, which is the brain tissue ...
(Date:5/17/2013)... The IUD safety advocates at DrugRisks.com are announcing ... the vaginal ring contraceptive NuvaRing. A recent report from ... blood clots from the devices has risen*. ... patients using popular prescription devices by providing the latest ... out if others are experiencing similar side effects and ...
Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4Health News:Is Menopause Overlooked in U.S. Medical Schools? 2Health News:Study identifies new approach to improving treatment for MS and other conditions 2Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2
... the NHS proposal to allow nurses to perform routine, ... as being equivalent to entrusting airhostesses // with the ... Medical Association (BMA) has been urged to alert the ... operations on patients. More than 130 doctors have indeed ...
... by the American Medical Association has left its readers tipsy with ... ,A survey of 644 female college students has revealed that breaking ... having fun in life. Three out of four women seem to ... drinking meant bingeing on booze, getting them all sick and drunk. ...
... is under pressure as it is asked to improve its ... who has had deep// ties with the company has her ... of directors for six years. Hillary Clinton said that her ... ,But in recent months, as the company has ...
... the Norfolk and Norwich University Hospital have been given the ... to women who test positive for her-2 gene. ... the therapeutic advisory groups, and the primary care trusts have ... the N&N. "About one in five women with breast cancer ...
... that British Asians are at least 50 percent more likely ... European origin. One in five has also developed type 2 ... in the UK. ,Of immediate concern are the ... blood pressure amongst South East Asians in the UK, said ...
... huge study involving 38 populations across 21 countries, reserachers have ... dropping.// ,"Blood pressure did not go down in ... of them," said Prof Tunstall-Pedoe, who led the World Health ... change was not great, but it did appear to have ...
Cached Medicine News:Health News:Doctors Protest Against Allowing Nurses To Perform Minor Surgeries 2
Fine .12mm Tip With 5mm Platform; In Titanium....
Curved 30mm shaft (in stainless steel); rubber coated for safer use; includes 1.5 meter cable and connectors....
Straight shafts with extra fine pointed tips and 6mm tying platform. Smooth handle with dull finish/...
... Advantage Chair and Stand is one of ... systems available, yet it does not compromise ... the use of durable mechanical components.,The Advantage ... the eyecare professional who demands the very ...
Medicine Products: